Sanofi Consumer Healthcare India Limited (NSE:SANOFICONR)
India flag India · Delayed Price · Currency is INR
4,577.60
-13.80 (-0.30%)
At close: Dec 16, 2025

NSE:SANOFICONR Income Statement

Millions INR. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023
Period Ending
Sep '25 Dec '24 Dec '23
7,9817,2458,331
Revenue Growth (YoY)
254.87%-13.04%-
Cost of Revenue
2,0531,8772,291
Gross Profit
5,9285,3686,041
Selling, General & Admin
1,4171,2351,050
Other Operating Expenses
1,6981,4271,709
Operating Expenses
3,2082,7072,786
Operating Income
2,7202,6613,255
Interest Expense
-19-39-
Interest & Investment Income
11811860
Currency Exchange Gain (Loss)
11-
Other Non Operating Income (Expenses)
69111.5
EBT Excluding Unusual Items
2,8892,7523,317
Asset Writedown
-29-29-
Other Unusual Items
66-255-27
Pretax Income
2,9262,4683,290
Income Tax Expense
747658816
Net Income
2,1791,8102,474
Net Income to Common
2,1791,8102,474
Net Income Growth
455.16%-26.82%-
Shares Outstanding (Basic)
232323
Shares Outstanding (Diluted)
232323
EPS (Basic)
94.6178.59107.40
EPS (Diluted)
94.6178.59107.40
EPS Growth
-51.80%-26.82%-
Free Cash Flow
-4,291-66
Free Cash Flow Per Share
-186.32-2.87
Dividend Per Share
-55.000-
Gross Margin
74.28%74.09%72.51%
Operating Margin
34.08%36.73%39.07%
Profit Margin
27.30%24.98%29.69%
Free Cash Flow Margin
-59.23%-0.79%
EBITDA
2,7382,6833,282
EBITDA Margin
34.31%37.03%39.40%
D&A For EBITDA
18.252227
EBIT
2,7202,6613,255
EBIT Margin
34.08%36.73%39.07%
Effective Tax Rate
25.53%26.66%24.81%
Revenue as Reported
8,1697,3758,393
Advertising Expenses
-181-
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.